Activated PI3K and RTK signaling and response/resistance to HER2 targeted therapy

被引：0
|
作者：
O'Brien, Neil
Browne, Brigid
Chow, Lucy
Ginther, Charles
Bensadigh, Brian
Atefi, Mohammad
Arboleda, Jane
Duffy, Michael
Crown, John
O'Donovan, Norma
Slamon, Dennis
机构：
[1] Univ Calif Los Angeles, Los Angeles, CA USA
[2] Natl Inst Cellular Biotechnol, Dublin, Ireland
[3] Conway Inst, UCD Sch Med & Med Sci, Dublin, Ireland
来源：
CANCER RESEARCH | 2009年 / 69卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
765
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Development of HER2 targeted therapy
    Tamura, Kenji
    CANCER SCIENCE, 2021, 112 : 158 - 158
  • [42] Targeting PI3K Signaling in Combination Cancer Therapy
    Pons-Tostivint, Elvire
    Thibault, Benoit
    Guillermet-Guibert, Julie
    TRENDS IN CANCER, 2017, 3 (06): : 454 - 469
  • [43] Targeting the PI3K signaling pathway in cancer therapy
    Bartholomeusz, Chandra
    Gonzalez-Angulo, Ana Maria
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2012, 16 (01) : 121 - 130
  • [44] A HER3 antibody that blocks ligand-independent HER2-HER3 dimerization sensitizes to HER2 and PI3K inhibitors.
    Garrett, Joan T.
    Sutton, Cammie R.
    Bialucha, Carl Uli
    Ettenberg, Seth A.
    Wallweber, Jerry
    DeFazio-Eli, Lisa
    Arteaga, Carlos L.
    CANCER RESEARCH, 2013, 73 (08)
  • [45] Ganoderma tsugae Extract Inhibits Growth of HER2-Overexpressing Cancer Cells via Modulation of HER2/PI3K/Akt Signaling Pathway
    Kuo, Han-Peng
    Hsu, Shih-Chung
    Ou, Chien-Chih
    Li, Jhy-Wei
    Tseng, Hsiu-Hsueh
    Chuang, Tzu-Chao
    Liu, Jah-Yao
    Chen, Shih-Jung
    Su, Muh-Hwan
    Cheng, Yung-Chi
    Chou, Wei-Yuan
    Kao, Ming-Ching
    EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2013, 2013
  • [46] HER2 mRNA Expression Is Influenced by Estrogen Receptor Status and PI3K Mutational Status
    Bloom, K. J.
    Choppa, P.
    Kyshtoobayeva, A.
    Barry, T.
    Goldstein, N.
    CANCER RESEARCH, 2010, 70
  • [47] DUAL-TARGETING OF AMPK AND PI3K/MTOR IN HER2 OVEREXPRESSING BREAST CANCER
    Russillo, Michelangelo
    Di Cosimo, Serena
    Serra, Violeta
    Scaltriti, Maurizio
    Rodriguez, Olga
    Cognetti, Francesco
    Baselga, Jose
    ANNALS OF ONCOLOGY, 2009, 20
  • [48] Differential induction of apoptosis in HER2 and EGFR addicted cancers following PI3K inhibition
    Faber, Anthony C.
    Li, Danan
    Song, YoungChul
    Liang, Mei-Chih
    Yeap, Beow Y.
    Bronson, Roderick T.
    Lifshits, Eugene
    Chen, Zhao
    Maira, Sauveur-Michel
    Garcia-Echeverria, Carlos
    Wong, Kwok-Kin
    Engelman, Jeffrey A.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2009, 106 (46) : 19503 - 19508
  • [49] Inhibition of PI3K pathway improves anti HER2 treatment efficacy in a panel of HER2 positive gastric cancer cell lines
    Gambardella, V.
    Llorca-Cardenosa, M. J.
    Castillo, J.
    Tarazona Llavero, N.
    Huerta, M.
    Rosello Keranen, S.
    Ibarolla-Villava, M.
    Ribas, G.
    Gil, A.
    Cervantes, A.
    ANNALS OF ONCOLOGY, 2016, 27
  • [50] Demethoxycurcumin induces apoptosis in HER2 overexpressing bladder cancer cells through degradation of HER2 and inhibiting the PI3K/Akt pathway
    Kao, Chien-Chang
    Cheng, Yi-Ching
    Yang, Ming-Hsin
    Cha, Tai-Lung
    Sun, Guang-Huan
    Ho, Chi-Tang
    Lin, Ying-Chao
    Wang, Hao-Kuang
    Wu, Sheng-Tang
    Way, Tzong-Der
    ENVIRONMENTAL TOXICOLOGY, 2021, 36 (11) : 2186 - 2195
12345